1. 156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine. (15th June 2018) Authors: Nash, Abigail; Shawi, May; Singh, Jaskaran; Daly, Ella; Copper, Kimberly; Lim, Pilar; Lane, Rosanne; Gogate, Jagadish; DiBernardo, Allitia; Hough, David; Alphs, Larry Journal: CNS spectrums Issue: Volume 23:Number 1(2018:Feb.) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single‐dose, open‐label, parallel, randomized, dose‐proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia. (3rd April 2014) Authors: Cleton, Adriaan; Rossenu, Stefaan; Crauwels, Herta; Berwaerts, Joris; Hough, David; Gopal, Srihari; Eerdekens, Marielle; Vandebosch, An; Remmerie, Bart; De Meulder, Marc; Fernández, Clara M. Rosso Journal: Journal of clinical pharmacology Issue: Volume 54:Number 9(2014:Sep.) Page Start: 1048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Approval of esketamine for treatment-resistant depression. (March 2020) Authors: Singh, Jaskaran B; Daly, Ella J; Mathews, Maju; Fedgchin, Maggie; Popova, Vanina; Hough, David; Drevets, Wayne C Journal: Lancet Issue: Volume 7:Number 3(2020) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients. (November 2016) Authors: Howard, Robert; Costafreda, Sergi G.; Karcher, Keith; Coppola, Danielle; Berlin, Jesse A.; Hough, David Journal: British journal of psychiatry Issue: Volume 209:Number 5(2016) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression. Issue 2 (13th October 2020) Authors: Katz, Eva G.; Hough, David; Doherty, Teodora; Lane, Rosanne; Singh, Jaskaran; Levitan, Bennett Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression. Issue 2 (13th October 2020) Authors: Katz, Eva G.; Hough, David; Doherty, Teodora; Lane, Rosanne; Singh, Jaskaran; Levitan, Bennett Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy. (July 2016) Authors: Alphs, Larry; Nasrallah, Henry A.; Bossie, Cynthia A.; Fu, Dong-Jing; Gopal, Srihari; Hough, David; Turkoz, Ibrahim Journal: International clinical psychopharmacology Issue: Volume 31:Number 4(2016:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Paliperidone palmitate 3-month treatment results in symptomatic remission in patients with schizophrenia: a randomized, multicenter, double-blind, and noninferiority study. (November 2017) Authors: Savitz, Adam J.; Xu, Haiyan; Gopal, Srihari; Nuamah, Isaac; Hough, David; Mathews, Maju Journal: International clinical psychopharmacology Issue: Volume 32:Number 6(2017:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?. Issue 6 (December 2016) Authors: Ravenstijn, Paulien; Samtani, Mahesh; Russu, Alberto; Hough, David; Gopal, Srihari Journal: Journal of clinical psychopharmacology Issue: Volume 36:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia. (2nd October 2016) Authors: Pierce, Phillip; Gopal, Srihari; Savitz, Adam; Qiu, Hong; Hino, Takahito; Busch, Michelle; Fujino, Akiko; Mathews, Maju; Katsu, Takeshi; Maeda, Yoshikazu; Takahashi, Masayoshi; Hough, David Journal: Current medical research and opinion Issue: Volume 32:Number 10(2016:Oct.) Page Start: 1671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗